Your browser doesn't support javascript.
loading
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial.
Tanaka, Atsushi; Inoue, Teruo; Kitakaze, Masafumi; Oyama, Jun-Ichi; Sata, Masataka; Taguchi, Isao; Shimizu, Wataru; Watada, Hirotaka; Tomiyama, Hirofumi; Ako, Junya; Sakata, Yasushi; Anzai, Toshihisa; Uematsu, Masaaki; Suzuki, Makoto; Eguchi, Kazuo; Yamashina, Akira; Saito, Yoshihiko; Sato, Yasunori; Ueda, Shinichiro; Murohara, Toyoaki; Node, Koichi.
Afiliação
  • Tanaka A; Department of Cardiovascular Medicine, Saga University, Saga, Japan.
  • Inoue T; Department of Cardiovascular Medicine, Dokkyo Medical University School of Medicine, Mibu, Japan.
  • Kitakaze M; Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Oyama J; Department of Advanced Cardiology, Saga University, Saga, Japan.
  • Sata M; Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
  • Taguchi I; Department of Cardiology, Koshigaya Hospital, Dokkyo Medical University, Koshigaya, Japan.
  • Shimizu W; Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
  • Watada H; Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Tomiyama H; Department of Cardiology, Tokyo Medical University, Tokyo, Japan.
  • Ako J; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Anzai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Uematsu M; Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Japan.
  • Suzuki M; Cardiology Department, Kameda Medical Center, Kamogawa, Japan.
  • Eguchi K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Yamashina A; Department of Cardiology, Tokyo Medical University, Tokyo, Japan.
  • Saito Y; First Department of Internal Medicine, Nara Medical University, Kashihara, Japan.
  • Sato Y; The Clinical Research Center, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Ueda S; Department of Clinical Pharmacology & Therapeutics, University of the Ryukyus School of Medicine, Okinawa, Japan.
  • Murohara T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan. node@cc.saga-u.ac.jp.
Cardiovasc Diabetol ; 15: 57, 2016 Apr 04.
Article em En | MEDLINE | ID: mdl-27044332
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Diabetes Mellitus Tipo 2 / Canagliflozina / Insuficiência Cardíaca / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Diabetes Mellitus Tipo 2 / Canagliflozina / Insuficiência Cardíaca / Hipoglicemiantes Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão